Effective treatment for schizophrenia is still an unmet clinical need. Alleviating problems associated with cognitive impairment and finding the root of the disease remain priorities for clinicians and scientists. The incomplete understanding of the basis of this pathology has urged for research that will unravel the genetic origin of schizophrenia. But studies involving environmental exposure and social impact have also hinted at extrinsic factors as players in the pathogenesis of schizophrenia, which may be exploited to prevent the development of the disease. In 'Bench to Bedside', Patrick Sullivan proposes a model putting forward how genetic variants may confer risk by functioning together within the same pathway. This disease pathway hypothesis would imply a polygenetic variation affecting the same pathway and the alteration of a transcriptional network as a root for increasing schizophrenia risk. In 'Bedside to Bench', Andreas Meyer-Linderberg and Heike Tost discuss human-based population studies that suggest that environmental factors linked to development of schizophrenia can affect brain regions involved in the human social-emotional processing network. Genetic risk variants for schizophrenia can also influence similar regions in the brain, suggesting that environmental and intrinsic factors may converge in the same neural circuit.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Functional patient-derived cellular models for neuropsychiatric drug discovery
Translational Psychiatry Open Access 17 February 2021
-
Unravelling socio-motor biomarkers in schizophrenia
npj Schizophrenia Open Access 01 February 2017
-
Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder
Translational Psychiatry Open Access 11 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van Os, J. & Kapur, S. Lancet 374, 635–645 (2009).
Collins, P.Y. et al. Nature 475, 27–30 (2011).
World Health Organization. The global burden of disease: 2004 update. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (2008).
Friedhoff, A.J. & Van Winkle, E. Nature 194, 897–898 (1962).
Sherrington, R. et al. Nature 336, 164–167 (1988).
Ripke, S. et al. Nat. Genet. 43, 969–976 (2011).
Levinson, D.F. et al. Am. J. Psychiatry 168, 302–316 (2011).
International Schizophrenia Consortium et al. Nature 460, 748–752 (2009).
Barabási, A.L., Gulbahce, N. & Loscalzo, J. Nat. Rev. Genet. 12, 56–68 (2011).
Lichtenstein, P. et al. Lancet 373, 234–239 (2009).
Stefansson, H. et al. Nature 460, 744–747 (2009).
Kwon, E., Wang, W. & Tsai, L.H. Mol. Psychiatry advance online publication, 10.1038/mp.2011.170 (20 December 2011).
Szulwach, K.E. et al. J. Cell Biol. 189, 127–141 (2010).
Smrt, R.D. et al. Stem Cells 28, 1060–1070 (2010).
Visscher, P.M. et al. Am. J. Hum. Genet. 90, 7–24 (2012).
Lee, S. et al. Nat. Genet. (in the press).
Voineagu, I. et al. Nature 474, 380–384 (2011).
Sullivan, P. Mol. Psychiatry 17, 2–3 (2011).
Yang, J., Wray, N.R. & Visscher, P.M. Genet. Epidemiol. 34, 254–257 (2010).
Lango Allen, H. et al. Nature 467, 832–838 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sullivan, P. Puzzling over schizophrenia: Schizophrenia as a pathway disease. Nat Med 18, 210–211 (2012). https://doi.org/10.1038/nm.2670
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2670
This article is cited by
-
Functional patient-derived cellular models for neuropsychiatric drug discovery
Translational Psychiatry (2021)
-
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks
Molecular Psychiatry (2020)
-
Unravelling socio-motor biomarkers in schizophrenia
npj Schizophrenia (2017)
-
G72 primate-specific gene: a still enigmatic element in psychiatric disorders
Cellular and Molecular Life Sciences (2016)
-
Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis
Nature Genetics (2015)